Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

19 trials with published results (9%)

Research Maturity

82 completed trials (38% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.5%

12 terminated out of 217 trials

Success Rate

87.2%

+0.7% vs benchmark

Late-Stage Pipeline

15%

33 trials in Phase 3/4

Results Transparency

23%

19 of 82 completed with results

Key Signals

19 with results87% success12 terminated

Data Visualizations

Phase Distribution

154Total
Not Applicable (89)
Early P 1 (2)
P 1 (12)
P 2 (18)
P 3 (7)
P 4 (26)

Trial Status

Completed82
Recruiting44
Unknown40
Not Yet Recruiting15
Active Not Recruiting12
Terminated12

Trial Success Rate

87.2%

Benchmark: 86.6%

Based on 82 completed trials

Clinical Trials (217)

Showing 20 of 20 trials
NCT07569640Phase 3Not Yet RecruitingPrimary

HFrEF Polypill in Sri Lanka RCT

NCT07086131Not ApplicableRecruitingPrimary

A Study Investigating the Impact of IMT With CR On Exercise Responses In HF

NCT06359938Not ApplicableCompletedPrimary

Respiratory Sinus Arrhythmia (RSA) Pacing Post-CABG Surgery in Patients With HFrEF

NCT06552637Not ApplicableRecruitingPrimary

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

NCT06736574Phase 3Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

NCT07695090Phase 2RecruitingPrimary

Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients

NCT06576297Not ApplicableCompleted

Novel Respiratory Training as Part of Palliative Care for Older Adults With Heart Failure

NCT06526988Not ApplicableRecruitingPrimary

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

NCT07697365CompletedPrimary

Vericiguat and Exercise Hemodynamics in Patients With HFrEF

NCT07599345CompletedPrimary

Emulation of the EMPEROR-Reduced Trial Using Healthcare Claims Data

NCT07465653Phase 1RecruitingPrimary

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

NCT05774509Phase 1Active Not RecruitingPrimary

Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells

NCT07214376Not ApplicableRecruiting

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

NCT07465679CompletedPrimary

A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

NCT07490067Phase 4RecruitingPrimary

Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score

NCT06241430Not ApplicableRecruitingPrimary

The CardioClip Study

NCT07631156Phase 4Not Yet RecruitingPrimary

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

NCT06423599Phase 2RecruitingPrimary

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

NCT07087613Recruiting

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

Scroll to load more

Research Network

Activity Timeline